Alerts will be sent to your verified email
Verify EmailBIOGEN
Biogen Pharmachem
|
Filtra Consultants
|
Dhanalaxmi Roto Spin
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
0.19 % | 14.05 % | 20.43 % |
5yr average Equity Multiplier
|
1.01 | 1.85 | 1.65 |
5yr Average Asset Turnover Ratio
|
0.02 | 2.36 | 2.43 |
5yr Avg Net Profit Margin
|
-19.83 % | 3.2 % | 5.25 % |
Price to Book
|
0.82 | 3.19 | 1.28 |
P/E
|
61.76 | 26.34 | 7.34 |
5yr Avg Cash Conversion Cycle
|
0.0 | 36.46 Days | 8.07 Days |
Inventory Days
|
0.0 | 55.87 Days | 4.2 Days |
Days Receivable
|
0.0 | 34.62 Days | 51.03 Days |
Days Payable
|
3.0 Days | 66.81 Days | 42.28 Days |
5yr Average Interest Coverage Ratio
|
902.8 | 65.13 | 13.94 |
5yr Avg ROCE
|
0.2 % | 19.83 % | 29.7 % |
5yr Avg Operating Profit Margin
|
-19.88 % | 4.39 % | 4.13 % |
5 yr average Debt to Equity
|
0.0 | 0.02 | 0.1 |
5yr CAGR Net Profit
|
-28.94 % | 9.36 % | 16.09 % |
5yr Average Return on Assets
|
0.19 % | 7.6 % | 12.42 % |
Shareholdings
|
|||
Promoter Holding
|
0.0 | 72.45 % | 47.64 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.73 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Biogen Pharmachem
|
Filtra Consultants
|
Dhanalaxmi Roto Spin
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|